Aridis Pharmaceuticals (ARDS)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Oct 14, 2024 03:49 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 0.00 | 1.37 | 9.99 |
Current Quarter Estimate | NA | 2.59 | 63.00 |
Year Ago Quarter Estimate | NA | -4.98 | 52.25 |
Next Quarter Estimate | NA | 3.37 | 66.00 |
Next Year Estimate | NA | 23.17 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 17.40 | 15.70 |
Next Year | NA | 10.00 | 11.30 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.28 |
Price/Book (MRQ) | NA | 1.95 |
Price/Cash Flow (MRFY) | NA | 14.78 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -101.26% |
Return on Equity (TTM) | NA | -66.38% |
Debt to Equity (MRQ) | NA | 40.92 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.